Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/1996
08/28/1996EP0728842A2 Live recombinant avian vaccine based on an avianherpes virus, against Gumboro disease
08/28/1996EP0728763A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor
08/28/1996EP0728752A1 Triazole compounds, their production and use
08/28/1996EP0728481A2 Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections
08/28/1996EP0728209A1 Endothelin-converting enzyme
08/28/1996EP0728203A1 Analogous peptides of the internal image of a viral protein
08/28/1996EP0728200A1 Haemophilus transferrin receptor genes
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728135A1 Urea derivatives
08/28/1996EP0728130A1 Pyrimidine-thioalkyl and alkylether compounds
08/28/1996EP0728017A1 Treatment of bacterially-induced inflammatory diseases
08/28/1996EP0728015A1 Combinatorial polypeptide antigens
08/28/1996EP0728014A1 Vaccines expressed in plants
08/28/1996EP0728002A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
08/28/1996EP0728001A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
08/28/1996EP0727999A1 Treatment of immunoregulatory disorders
08/28/1996EP0727998A1 Oxazoles for treating cytokine mediated diseases
08/28/1996EP0727993A1 (non descriptive)-a method for delaying hiv individual aids by administration of substituted azaspirane compounds
08/28/1996EP0727979A1 Novel composition
08/28/1996EP0727978A1 Topical aromatic releasing compositions
08/28/1996EP0420872B1 Therapeutic uses of 2',5'-oligoadenylate derivatives
08/28/1996CN1129573A Skin absorptive antiviral drug
08/28/1996CN1032650C Thiourea derivatives and antimicrobial agent and antiulcer agent containing same
08/28/1996CA2170222A1 Use of quinoxalines in combination with protease inhibitors as medicaments for treating aids and/or hiv infections
08/27/1996US5550243 B preparation of 2- and 3- azido derivates of 1,5-iminosugars
08/27/1996US5550232 Diastereomers of 1-(isopropoxycarbonyloxy) ethyl 3-cephem 4-carboxylate
08/27/1996US5550231 Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
08/27/1996US5550223 Lipoprotein I (ompi) of pseudomonas aeruginosa
08/27/1996US5550145 Bactericides or fungicides as preservatives for cosmetics
08/27/1996US5550142 Phenyl heterocycles as cox-2 inhibitors
08/27/1996US5550135 Heterocycle-substituted benzenemethanamine derivatives
08/27/1996US5550049 Useful as insecticides and arachnicidic agents
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996US5549897 High molecular weight surface proteins of non-typeable haemophilus
08/27/1996US5549893 Use of protein C in the treatment of purpura fulminans
08/27/1996CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
08/27/1996CA2004366C Anti-infection and antithrombogenic medical articles and method for their preparation
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025520A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025492A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
08/22/1996WO1996025430A1 Helicobacter pylori antigen
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025171A1 Inhibition of angiogenesis using interleukin-12
08/22/1996WO1996025167A1 Anti-viral triaza compounds
08/22/1996WO1996019498A3 T cell stimulating protein of pestivirus
08/22/1996CA2213132A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996CA2212952A1 Helicobacter pylori antigen
08/22/1996CA2212370A1 Inhibition of angiogenesis using interleukin-12
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2211920A1 Anti-viral triaza compounds
08/22/1996CA2210538A1 Eukaryotic initiation factor 5a (eif-5a) mutants
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/21/1996EP0727483A2 Retrovirus of the HIV-group and its application
08/21/1996EP0727433A1 Process for the preparation of 1-(2'-deoxy-2',2'-difluoro-d-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-beta-d-ribo-pentopyranose
08/21/1996EP0727426A2 Cephalosporin derivatives
08/21/1996EP0727419A2 Retroviral protease inhibiting compounds
08/21/1996EP0726957A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
08/21/1996EP0726952A1 Receptor on the surface of activated t-cells:acts-4
08/21/1996EP0726944A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
08/21/1996EP0726941A1 METHODS FOR $i(EX VIVO) THERAPY USING PEPTIDE-LOADED ANTIGEN PRESENTING CELLS FOR THE ACTIVATION OF CTL
08/21/1996EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
08/21/1996EP0726776A1 Inhibition of hiv mucosal infection
08/21/1996EP0726774A1 Vaccine design and production
08/21/1996EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/21/1996EP0726704A1 Method of introducing material into eggs during early embryonic development
08/21/1996EP0614457B1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments
08/21/1996EP0589949B1 New peptides (didemnins), their preparation and their use
08/21/1996EP0589893B1 Use of a bacteriocin antimicrobial agent for the manufacture of a medicament for the treatment of gastric disorders associated with Helicobacter pylori.
08/21/1996CN1129460A Epstein-barr virus dna sequences encoding diagnostically relevant virus capid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic
08/21/1996CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/21/1996CN1129223A Method for preparing 1-N-ethylsisomicin
08/21/1996CN1129220A Novel crystalline cephem acid addition salts and processes for their preparation
08/21/1996CN1129102A Catechol diether compounds as inhibitors of TNF release
08/20/1996US5547992 Anti-herpes virus and cytomegalovirus polycarbonate oligomers
08/20/1996US5547976 Viricides, herpes virus, cytomegalovirus; cardiovascular disorders
08/20/1996US5547970 Use of leflunomide for inhibiting tumor necrosis factor alpha
08/20/1996US5547962 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
08/20/1996US5547959 For treatment of the autoimmune disease systemic lupus erythematosus
08/20/1996US5547951 Enzyme inhibitors; aids
08/20/1996US5547950 Oxazolidinone antimicrobials containing substituted diazine moieties
08/20/1996US5547941 Cyclic dinucleoside diphosphorothioates, related compounds and pharmaceutical compositions
08/20/1996US5547939 Broad spectrum antimicrobial compounds and methods of use
08/20/1996US5547932 Transfection
08/20/1996US5547670 Polypeptides
08/20/1996US5547666 Antibiotic GE 2270 factors A1, A2, A3 and H
08/20/1996US5547664 Expression of recombinant proteins in attenuated bacteria
08/20/1996CA1338532C 2',3'-dideoxy purine nucleosides and process for the preparation thereof
08/16/1996CA2169400A1 Cephalosporin derivatives
08/15/1996WO1996024684A1 Potentiators of antibacterial agents
08/15/1996WO1996024613A1 A process for preparing certain aza cyclohexapeptides
08/15/1996WO1996024608A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996WO1996024607A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996WO1996024378A2 Delivery of exogenous compounds
08/15/1996WO1996024375A1 New oral pharmaceutical dosage form
08/15/1996WO1996024371A1 Multifunctional enzyme
08/15/1996WO1996024367A1 Pharmaceutical composition for the treatment of herpes
1 ... 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 ... 1798